Inventor · disambiguated record
Benjamin S. Bleier
Also filed as: BLEIER BENJAMIN S
13 granted patents·8 pending applications·90 citations·filing 2009–2024
91Inventor score
Files withMASSACHUSETTS EYE & EAR INFIRMARY15MASSACHUSETTS EYE & EAR INFIRM2UNIV NORTHEASTERN2BLEIER BENJAMIN S1UNIV PENNSYLVANIA1
Top patents by PatentIndex Score
21 records- 0197US9517200B2Methods of delivering pharmaceutical agentsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Dec 13, 2016·46 cites·22 claims
- 0296US11786574B2Treatment of rhinosinusitis with p-glycoprotein inhibitorsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2021·Granted Oct 17, 2023·4 cites·9 claims
- 0394US11007246B2Treatment of rhinosinusitis with P-glycoprotein inhibitorsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted May 18, 2021·5 cites·18 claims
- 0493US10653745B2Treatment of rhinosinusitis with P-glycoprotein inhibitorsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted May 19, 2020·5 cites·21 claims
- 0593US9744210B2Treatment of rhinosinusitis with P-glycoprotein inhibitorsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2013·Granted Aug 29, 2017·8 cites·22 claims
- 0690US8945600B2Methods of delivering pharmaceutical agentsMASSACHUSETTS EYE & EAR INFIRM·Filed 2014·Granted Feb 3, 2015·5 cites·22 claims
- 0786US12268726B2Treatment of rhinosinusitis with P-glycoprotein inhibitorsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2023·Granted Apr 8, 2025·0 cites·27 claims
- 0882US11408900B2Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitisMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted Aug 9, 2022·3 cites·16 claims
- 0982US8673338B2Methods of delivering pharmaceutical agentsBLEIER BENJAMIN S·Filed 2012·Granted Mar 18, 2014·13 cites·24 claims
- 1076US9084756B2Methods of delivering pharmaceutical agentsMASSACHUSETTS EYE & EAR INFIRM·Filed 2015·Granted Jul 21, 2015·1 cites·22 claims
- 1174US2025244341A1Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic RhinosinusitisMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2024·Application pending·0 cites
- 1270US2024423903A1Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the BrainUNIV NORTHEASTERN·Filed 2024·Application pending·0 cites
- 1366US2023111968A1Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic RhinosinusitisMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2022·Application pending·0 cites
- 1464US12121608B2Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brainUNIV NORTHEASTERN·Filed 2021·Granted Oct 22, 2024·0 cites·17 claims
- 1564US9439852B2Methods of delivering pharmaceutical agentsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Sep 13, 2016·0 cites·23 claims
- 1656US2023226008A1Combination Verapamil and Mometasone Therapy for the treatment of Chronic RhinosinusitisMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2021·Application pending·0 cites
- 1756US2024181231A1Submucosal implantable drug delivery apparatuses, systems, and methodsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2022·Application pending·0 cites
- 1853US12295933B2Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavityMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2020·Granted May 13, 2025·0 cites·20 claims
- 1950US2011172704A1Solder formulation and use in tissue weldingUNIV PENNSYLVANIA·Filed 2009·Application pending·0 cites
- 2048US2023159659A1Inhibition of cystatins for the treatment of chronic rhinosinusitisMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Application pending·0 cites
- 2145US2021023295A1Submucosal drug delivery apparatuses, systems, and methodsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin S. Bleier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →